Innovating Works

H2020

Cerrada
HORIZON-JU-IHI-2022-01-04
HORIZON-JU-IHI-2022-01-04: Access and integration of heterogeneous health data for improved healthcare in disease areas of high unmet public health need
ExpectedOutcome:Proposals under this topic should aim to deliver results that contribute to all of the following expected outcomes for a specified disease area of high unmet public health need1:
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 20-09-2022.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

ExpectedOutcome:Proposals under this topic should aim to deliver results that contribute to all of the following expected outcomes for a specified disease area of high unmet public health need1:

Researchers, including industry stakeholders, have long-term access to diverse data at scale, enabled by the linkage and integration of novel and cross-sectoral sources, including industry sources. If possible, some of these data should be able to be used for providing evidence to support regulatory decision-making.Researchers, including industry stakeholders, have long-term access to new tools that enable the integration and analysis of these data. If possible, some of these tools should be able to be used for providing evidence to support regulatory decision-making.Citizens, including patients, are given user-friendly, interoperable tools to access their own health data from different sources to support disease self-management and empower joint health care professional - patient decision making.Health care professionals and healthcare providers2 have access to integrated data from diverse sources and clinical (and other) decision support systems to deliver better healthcare s... ver más

ExpectedOutcome:Proposals under this topic should aim to deliver results that contribute to all of the following expected outcomes for a specified disease area of high unmet public health need1:

Researchers, including industry stakeholders, have long-term access to diverse data at scale, enabled by the linkage and integration of novel and cross-sectoral sources, including industry sources. If possible, some of these data should be able to be used for providing evidence to support regulatory decision-making.Researchers, including industry stakeholders, have long-term access to new tools that enable the integration and analysis of these data. If possible, some of these tools should be able to be used for providing evidence to support regulatory decision-making.Citizens, including patients, are given user-friendly, interoperable tools to access their own health data from different sources to support disease self-management and empower joint health care professional - patient decision making.Health care professionals and healthcare providers2 have access to integrated data from diverse sources and clinical (and other) decision support systems to deliver better healthcare services to patients and populations in the most suitable and efficient manner. 1 Unmet public health needs are needs currently not addressed by healthcare systems for various reasons, for example if no medicines are known to treat a disease. Areas of public health importance are those where the burden of disease is high for patients and society due to the severity of the disease (in terms of mortality, physical and functional impairment, comorbidities, loss of quality of life…) and/or the number of people affected by it. For example, Alzheimer’s disease.

2 The term ’healthcare providers’ refers to organisations that deliver healthcare goods and services. Typical healthcare providers are hospitals, long-term care facilities, providers of ambulatory healthcare, laboratories, nursing care facilities, pharmacies and so on.


Scope:Over the past few years, there has been an explosion in the generation of data that could be harnessed for use in healthcare delivery and research. These data include data generated by digital technologies and patient reported outcome and experience measures, as well as data from clinical trials and routine clinical care. However, accessing, integrating & analysing these data to maximise the value for patient care and research is extremely challenging.

This topic aims to provide a scalable platform for the seamless integration or linkage of these diverse data at scale, and develop tools to allow the data to be used in clinical care, patient self-management and research in disease areas of high unmet public health.

For their proposed activities applicants should clearly identify a disease area of high unmet public health need1 taking into account comorbidities and/or functional status, and explain their choice with empirical evidence where possible.

Develop / further develop a scalable, open platform for the seamless integration or linkage of data at scale from diverse public and private data sources relevant to the disease area selected. These data sources should, as a minimum, include all of the following: clinical trials; registries; patient safety data; routine clinical care; publicly available health insurance data; patient reported outcome and experience measures; and data generated by digital technologies such as sensors, wearables and mHealth apps. Preferably, projects should also integrate data that has not usually been used before for the purpose of medical decision-making.Develop / further develop tools focused on the needs of patients, leveraging these diverse data sources to support patient self-management and empower joint healthcare professional - patient decision making.Develop / further develop clinical (and other) decision support systems leveraging these diverse data sources to allow clinicians to deliver better healthcare services to patients in the disease area selected.Demonstrate the added value of the platform and tools compared to current approaches through a use case (study) applied to the disease area selected.Demonstrate the widespread applicability and scalability of the platform & tools using data sources from outside of the projectPublish sufficient information, including access protocols, on the data that has been used in the project to facilitate long-term access and re-use, while ensuring compliance with the General Data Protection Regulation and other relevant European legislation. Applicants should also aim to deliver the following:

Public release of a set of minimum technical requirements for the developed platform/tools that includes interoperability, connectivity, data protection, cybersecurity and authentication/identification requirements that need to be met to allow the efficient integration of additional data from new devices/sensors/sources into the decision-support system after the project ends.Sustainable, ideally open-source tools that help ensure the quality and FAIRness[1] of data at source (e.g., automated tools to help data entry, semantic coding, and data management in particular in registries and databases maintained by healthcare professionals/providers and research institutions) as well as methodologies, quality standards and metrics to assess data quality.Sustainable tools to increase cross-border and cross-sector interoperability of health data from the diverse sources mentioned above. Ideally, these tools use open exchange formats and take into account relevant EU initiatives including the eHealth Digital Services Infrastructure (eHDSI)2 and the European Electronic Health Record Exchange Format (EEHRxF)3Sustainability plan/business model to ensure the long-term impact of the project results. Other considerations:

Applicants should build on clearly identified existing tools & platforms where possible, and ensure that the platform and tools developed can be applied to other disease areas or be relevant for other scientific and clinical communities (i.e. ensuring interoperability with other solutions). If applicants choose to develop a new data platform, a strong justification must be provided.Applicants must demonstrate that they have access to sufficient diverse data, including from industry sources, to meet the objectives of this topic. The data sources (name & country), types, and size must be described in the proposal alongside convincing evidence that the consortium will have access to these data for the project implementation.During their activities, applicants should ensure appropriate engagement of the end-users of the developed tools, especially patients and healthcare professionals.Applicants are expected to explore the integration of the outputs with the European Health Data Space (EHDS)4 when it becomes operational, and explore synergies with other relevant health data initiatives and projects. 1 Unmet public health needs are needs currently not addressed by healthcare systems for various reasons, for example if no medicines are known to treat a disease. Areas of public health importance are those where the burden of disease is high for patients and society due to the severity of the disease (in terms of mortality, physical and functional impairment, comorbidities, loss of quality of life…) and/or the number of people affected by it. For example, Alzheimer’s disease.

2 http://ec.europa.eu/health/ehealth-digital-health-and-care/electronic-cross-border-health-services_en

3 http://ec.europa.eu/digital-single-market/en/news/recommendation-european-electronic-health-record-exchange-format

4 http://ec.europa.eu/health/ehealth/dataspace_en


Expected Impact:This topic aims to achieve the following:

Better and faster integration of future products, services and tools along the healthcare pathway, responding to patients’ specific needs and leading to improved health outcomes, patient safety and patient well-being.Wider availability of interoperable, large scale, quality data, respecting FAIR principles1 facilitating research and the development of integrated products and services.Advanced analytics/artificial intelligence (AI) supporting health research & innovation, resulting in:a) clinical decision support for increased accuracy of diagnosis and efficacy of treatment;b) wider availability of personalised health interventions to end-users;c) better evidence of the added value of new digital health and AI tools, including reduced risk of bias due to improved methodologies. 1 Wilkinson, M., Dumontier, M., Aalbersberg, I. et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data 3, 160018 (2016). https://doi.org/10.1038/sdata.2016.18


[1]

ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:
Empresas Micro, Pequeña, Mediana, Grande
Centros Tecnológicos
Universidades
Organismos públicos

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: ExpectedOutcome:Proposals under this topic should aim to deliver results that contribute to all of the following expected outcomes for a specified disease area of high unmet public health need1: ExpectedOutcome:Proposals under this topic should aim to deliver results that contribute to all of the following expected outcomes for a specified disease area of high unmet public health need1:
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Subcontracting costs.
Purchase costs.
Other cost categories.
Indirect costs.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 4:. Es el primer paso para determinar si los componentes individuales funcionarán juntos como un sistema en un entorno de laboratorio. Es un sistema de baja fidelidad para demostrar la funcionalidad básica y se definen las predicciones de rendimiento asociadas en relación con el entorno operativo final. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Para el presupuesto subvencionable la intensidad de la ayuda en formato fondo perdido podrá alcanzar como minimo un 100%.
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations. The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.